UBS AM’s Akero Therapeutics AKRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.74M | Sell |
|
|||||
|
2025
Q2 | $8.62M | Buy |
|
|||||
|
2025
Q1 | $4.45M | Buy |
|
|||||
|
2024
Q4 | $1.99M | Buy |
|
|||||
|
2024
Q3 | $1.73M | Sell |
|
|||||
|
2024
Q2 | $1.54M | Buy |
|
|||||
|
2024
Q1 | $1.18M | Hold |
|
|||||
|
2023
Q4 | $1.09M | Hold |
|
|||||
|
2023
Q3 | $2.35M | Buy |
|
|||||
|
2023
Q2 | $1.46M | Hold |
|
|||||
|
2023
Q1 | $1.46M | Buy |
|
|||||
|
2022
Q4 | $1.97M | Buy |
|
|||||
|
2022
Q3 | $838K | Sell |
|
|||||
|
2022
Q2 | $320K | Buy |
|
|||||
|
2022
Q1 | $265K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $212K | Sell |
|
|||||
|
2020
Q4 | $217K | Hold |
|
|||||
|
2020
Q3 | $259K | Buy |
|